Publication Date
| In 2025 | 1 |
| Since 2024 | 1 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Autism Spectrum Disorders | 1 |
| Barriers | 1 |
| Clinical Diagnosis | 1 |
| Databases | 1 |
| Ethnicity | 1 |
| Gender Differences | 1 |
| Genetic Disorders | 1 |
| Health Insurance | 1 |
| Individual Characteristics | 1 |
| Intellectual Disability | 1 |
| Neurodevelopmental Disorders | 1 |
| More ▼ | |
Source
| Autism: The International… | 1 |
Author
| Amelia Evans | 1 |
| Andryella Maxie Ibarra | 1 |
| Aracelly Valdes | 1 |
| Emily Val Tuliao | 1 |
| Isabella Quinon | 1 |
| Joelle Wadei | 1 |
| Kai Russell | 1 |
| Kyla Arcebido | 1 |
| Sabrina Barella | 1 |
| Samantha Gefen | 1 |
| Sohum Shinkre | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkKyla Arcebido; Emily Val Tuliao; Andryella Maxie Ibarra; Kai Russell; Aracelly Valdes; Sohum Shinkre; Samantha Gefen; Amelia Evans; Sabrina Barella; Joelle Wadei; Isabella Quinon; Takahiro Soda – Autism: The International Journal of Research and Practice, 2025
Genetic tests, such as Fragile X and Chromosomal Microarray, are recommended as a standard of care during the evaluation of autism spectrum disorder (ASD) and other neurodevelopmental disorders. However, previous research demonstrates low rates of genetic testing. This study aimed to identify the rates of genetic testing and patient demographic…
Descriptors: Genetic Disorders, Autism Spectrum Disorders, Neurodevelopmental Disorders, Databases
